22 February 2022

Quarantine of Specific Lots of the Medical Device Jagtome™ RX, Hydratome™ RX, Dreamtome™ RX, Cannulating Sphincterotomes, and Jagtome™ RX R

Reference: CIR-2022-00000042

To all Health facilities / all health care practitioners in Dubai's private health sector

Referring to the above subject, DHA notifies all health facilities regarding the circular issued by the MOHAP for perusal and adhere to what is stated

 

- Quarantine of Specific Lots of the Medical Device Jagtome™ RX, Hydratome™ RX, Dreamtome™ RX, Cannulating Sphincterotomes, and Jagtome™ RX R

 - Jagtome affected lots

 

 

 

Thanks in advance for your good co-operation

Drug Control Section

Health Regulation Sector

DHA

Supporting Documents:

Jagtome™ RX Hydratome™ الطبية RX Dreamtome™ RX Cannulating حجر تشغيلات-1.pdf:

View Document

Jagtome affected lots.pdf:

View Document